{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T05:06:46Z","timestamp":1781932006479,"version":"3.54.5"},"reference-count":47,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.brachy.2017.02.003","type":"journal-article","created":{"date-parts":[[2017,3,18]],"date-time":"2017-03-18T19:17:50Z","timestamp":1489864670000},"page":"608-615","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Dosimetric comparison between treatment plans of patients treated with low-dose-rate vs. high-dose-rate interstitial prostate brachytherapy as monotherapy: Initial findings of a randomized clinical trial"],"prefix":"10.1016","volume":"16","author":[{"given":"T.","family":"Major","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Polg\u00e1r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Jorgo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Stelczer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"\u00c1goston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2017.02.003_bib1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.5114\/jcb.2013.34342","article-title":"Low-dose-rate or high-dose-rate brachytherapy in treatment of prostate cancer\u2014Between options","volume":"5","author":"Skowronek","year":"2013","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.brachy.2017.02.003_bib2","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.brachy.2014.11.015","article-title":"Permanent seed brachytherapy for clinically localized prostate cancer: Long-term outcomes in a 700 patient cohort","volume":"14","author":"Martinez","year":"2015","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2017.02.003_bib3","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.radonc.2009.12.012","article-title":"Review of intraoperative imaging and planning techniques in permanent seed prostate brachytherapy","volume":"94","author":"Polo","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2017.02.003_bib4","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.ejmp.2012.07.004","article-title":"Treatment technique evolution and dosimetry trends over seven years of low dose rate prostate brachytherapy at an Australian institution","volume":"29","author":"Rutten","year":"2013","journal-title":"Physica Med"},{"key":"10.1016\/j.brachy.2017.02.003_bib5","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ijrobp.2010.05.042","article-title":"Fifteen-year biochemical relapse-free survival, cause-specific survival, and overall survival following I(125) prostate brachytherapy in clinically localized prostate cancer: Seattle experience","volume":"81","author":"Sylvester","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2017.02.003_bib6","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13014-015-0349-0","article-title":"Iodine-125 seed brachytherapy for early stage prostate cancer: A single-institution review","volume":"10","author":"Zuber","year":"2015","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.brachy.2017.02.003_bib7","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.brachy.2011.01.003","article-title":"Moderate dose escalation with single-fraction high-dose-rate brachytherapy boost for clinically localized intermediate- and high-risk prostate cancer: 5-year outcome of the first 100 consecutively treated patients","volume":"10","author":"\u00c1goston","year":"2011","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2017.02.003_bib8","first-page":"137","article-title":"HDR brachytherapy of prostate cancer\u2014Two years experience in Greater Poland Cancer Centre","volume":"1","author":"Kanikowski","year":"2009","journal-title":"J Contemp Brachyther"},{"key":"10.1016\/j.brachy.2017.02.003_bib9","doi-asserted-by":"crossref","first-page":"104","DOI":"10.5114\/jcb.2016.59216","article-title":"Single-fraction high-dose-rate brachytherapy using real-time transrectal ultrasound based planning in combination with external beam radiotherapy for prostate cancer: Dosimetrics and early clinical results","volume":"8","author":"Lauche","year":"2016","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.brachy.2017.02.003_bib10","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.ctrv.2013.10.006","article-title":"High dose rate brachytherapy boost for prostate cancer: A systematic review","volume":"40","author":"Zaorsky","year":"2014","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.brachy.2017.02.003_bib11","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/j.ijrobp.2010.09.006","article-title":"High-dose rate brachytherapy as a monotherapy for favourable prostate cancer: A phase II trial","volume":"82","author":"Barkati","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2017.02.003_bib12","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.brachy.2014.03.002","article-title":"High-dose-rate brachytherapy as monotherapy for prostate cancer","volume":"13","author":"Demanes","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2017.02.003_bib13","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.ijrobp.2011.05.001","article-title":"High-dose-rate brachytherapy as monotherapy delivered in two fractions within one day for favorable\/intermediate-risk prostate cancer: Preliminary toxicity data","volume":"83","author":"Ghilezan","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2017.02.003_bib14","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.ijrobp.2015.07.2290","article-title":"High-dose-rate monotherapy for localized prostate cancer: 10-year results","volume":"94","author":"Hauswald","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2017.02.003_bib15","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.ijrobp.2015.10.011","article-title":"Outcomes associated with 3 treatment schedules of high-dose-rate brachytherapy monotherapy for favorable-risk prostate cancer","volume":"94","author":"Jawad","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2017.02.003_bib16","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00066-004-1215-4","article-title":"3D conformal HDR brachytherapy as monotherapy for localized prostate cancer. A pilot study","volume":"180","author":"Martin","year":"2004","journal-title":"Strahlenther Oncol"},{"key":"10.1016\/j.brachy.2017.02.003_bib17","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0360-3016(00)00687-8","article-title":"High-dose-rate interstitial brachytherapy as a monotherapy for localized prostate cancer: Treatment description and preliminary results of a phase I\/II clinical trial","volume":"48","author":"Yoshioka","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2017.02.003_bib18","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.ijrobp.2015.05.044","article-title":"High-dose-rate brachytherapy as monotherapy for intermediate- and high-risk prostate cancer: Clinical results for a median 8-year follow-up","volume":"94","author":"Yoshioka","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2017.02.003_bib19","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ejmp.2011.12.005","article-title":"Evaluation of clinical benefits achievable by using different optimization algorithms during real-time prostate brachytherapy","volume":"29","author":"Adamczyk","year":"2013","journal-title":"Phys Med"},{"key":"10.1016\/j.brachy.2017.02.003_bib20","first-page":"203","article-title":"Robustness of IPSA optimized high-dose-rate prostate brachytherapy treatment plans to catheter displacements","volume":"8","author":"Poder","year":"2016","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.brachy.2017.02.003_bib21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.radonc.2007.01.014","article-title":"Tumour and target volumes in permanent prostate brachytherapy: A supplement to the ESTRO\/EAU\/EORTC recommendations on prostate brachytherapy","volume":"83","author":"Salembier","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2017.02.003_bib22","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.brachy.2015.09.010","article-title":"Comparison of dose and catheter optimization algorithms in prostate high-dose-rate brachytherapy","volume":"15","author":"Poulin","year":"2015","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2017.02.003_bib23","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0360-3016(96)00365-3","article-title":"Optimization of permanent 125I prostate implants using fast simulated annealing","volume":"36","author":"Pouliot","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2017.02.003_bib24","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/S0167-8140(05)81018-7","article-title":"HIPO: A hybrid inverse treatment planning optimization algorithm in HDR brachytherapy","volume":"76","author":"Karabis","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2017.02.003_bib25","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1120\/jacmp.v14i4.4198","article-title":"Evaluation of hybrid inverse planning and optimization (HIPO) algorithm for optimization in realtime, high-dose-rate (HDR) brachytherapy for prostate","volume":"14","author":"Pokharel","year":"2013","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.brachy.2017.02.003_bib26","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.ijrobp.2009.04.002","article-title":"Correlation between pre- and postimplant dosimetry for iodine-125 seed implants for localized prostate cancer","volume":"75","author":"Al-Qaisieh","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2017.02.003_bib27","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S1538-4721(03)00005-9","article-title":"Comparison of intraoperative dosimetric implant representation with postimplant dosimetry in patients receiving prostate brachytherapy","volume":"2","author":"Stone","year":"2003","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2017.02.003_bib28","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0360-3016(97)00732-3","article-title":"A conformal index (COIN) to evaluate implant quality and dose specification in brachytherapy","volume":"40","author":"Baltas","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2017.02.003_bib29","doi-asserted-by":"crossref","first-page":"91","DOI":"10.5114\/jcb.2014.42026","article-title":"High-dose-rate brachytherapy as monotherapy for prostate cancer: Technique, rationale and perspective","volume":"6","author":"Yoshioka","year":"2014","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.brachy.2017.02.003_bib30","doi-asserted-by":"crossref","first-page":"10","DOI":"10.5114\/jcb.2015.48838","article-title":"High-dose-rate brachytherapy delivered in two fractions as monotherapy for low-risk prostate cancer","volume":"7","author":"Cendales","year":"2015","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.brachy.2017.02.003_bib31","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.radonc.2013.09.025","article-title":"High-dose-rate brachytherapy alone given as two or one fraction to patients for locally advanced prostate cancer: Acute toxicity","volume":"110","author":"Hoskin","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2017.02.003_bib32","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ijrobp.2013.10.016","article-title":"Comparison of different fractionation schedules toward a single fraction in high-dose-rate brachytherapy as monotherapy for low-risk prostate cancer using 3-dimensional radiobiological models","volume":"88","author":"Mavroidis","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2017.02.003_bib33","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.radonc.2016.04.006","article-title":"High-dose-rate interstitial brachytherapy as monotherapy in one fraction for the treatment of favorable stage prostate cancer: Toxicity and long-term biochemical results","volume":"119","author":"Prada","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2017.02.003_bib34","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.radonc.2013.05.002","article-title":"GEC\/ESTRO recommendations on high dose rate afterloading brachytherapy for localised prostate cancer: an update","volume":"107","author":"Hoskin","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2017.02.003_bib35","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.brachy.2011.07.005","article-title":"American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy","volume":"11","author":"Davis","year":"2012","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2017.02.003_bib36","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.brachy.2011.09.008","article-title":"American Brachytherapy Society consensus guidelines for high-dose-rate prostate brachytherapy","volume":"11","author":"Yamada","year":"2012","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2017.02.003_bib37","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.brachy.2005.01.002","article-title":"Critical organ dosimetry in permanent seed prostate brachytherapy: Defining the organs at risk","volume":"4","author":"Crook","year":"2005","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2017.02.003_bib38","doi-asserted-by":"crossref","first-page":"45","DOI":"10.5114\/jcb.2012.27951","article-title":"Progressive transition from pre-planned to intraoperative optimizing seed implant: Post\u00a0implementation analysis","volume":"4","author":"Kuo","year":"2012","journal-title":"J Contemp Brachyther"},{"key":"10.1016\/j.brachy.2017.02.003_bib39","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1007\/s00066-012-0242-9","article-title":"Impact of learning curve and technical changes on dosimetry in low-dose brachytherapy for prostate cancer","volume":"188","author":"Le Fur","year":"2012","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.brachy.2017.02.003_bib40","doi-asserted-by":"crossref","first-page":"252","DOI":"10.5114\/jcb.2015.53526","article-title":"Reduced dose to urethra and rectum with the use of variable needle spacing in prostate brachytherapy: A potential role for robotic technology","volume":"7","author":"Vyas","year":"2015","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.brachy.2017.02.003_bib41","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.radonc.2010.02.012","article-title":"Loose seeds versus stranded seeds in I-125 prostate brachytherapy: Differences in clinical outcome","volume":"96","author":"Hinnen","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2017.02.003_bib42","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.ejmp.2014.08.002","article-title":"Loose versus stranded seeds in permanent prostate brachytherapy: Dosimetric comparison of intraoperative plans","volume":"30","author":"Major","year":"2014","journal-title":"Physica Med"},{"key":"10.1016\/j.brachy.2017.02.003_bib43","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.radonc.2008.09.013","article-title":"Decline of dose coverage between intraoperative planning and post implant dosimetry for I-125 permanent prostate brachytherapy: Comparison between loose and stranded seed implants","volume":"90","author":"Moerland","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2017.02.003_bib44","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.radonc.2004.08.004","article-title":"Quality of permanent prostate implants using automated delivery with seedSelectrone versus manual insertion of RAPID Strands","volume":"73","author":"Van Gellekom","year":"2004","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2017.02.003_bib45","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.brachy.2014.09.006","article-title":"A comparison of inverse optimization algorithms for HDR\/PDR prostate brachytherapy treatment planning","volume":"14","author":"Dinkla","year":"2015","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2017.02.003_bib46","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.brachy.2015.01.004","article-title":"High-dose-rate brachytherapy as a monotherapy for prostate cancer\u2014Single-institution results of the extreme fractionation regimen","volume":"14","author":"Kukielka","year":"2015","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2017.02.003_bib47","first-page":"148","article-title":"Intraoperative and post-implant dosimetry in patients treated with permanent prostate implant brachytherapy","volume":"59","author":"Herein","year":"2015","journal-title":"Hungarian Oncol"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472117300399?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472117300399?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:11:07Z","timestamp":1761531067000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472117300399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S1538472117300399"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2017.02.003","relation":{},"ISSN":["1538-4721"],"issn-type":[{"value":"1538-4721","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dosimetric comparison between treatment plans of patients treated with low-dose-rate vs. high-dose-rate interstitial prostate brachytherapy as monotherapy: Initial findings of a randomized clinical trial","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2017.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}